
Parabilis Medicines Appoints Alan M. Sebulsky to Board of Directors
Parabilis Medicines Appoints Alan M. Sebulsky to Board of Directors Parabilis Medicines, a clinical-stage biopharmaceutical company focused on developing innovative therapies through its proprietary Helicon™ peptide platform, has announced the appointment of veteran biopharmaceutical finance executive Alan M. Sebulsky to…












